Search Results

116P Any regression of tumor (ART) as an intermediate endpoint in patients (pts) treated with immune checkpoint inhibitors (ICI): A pan-cancer analysis.

• Authors : El Zarif, T.¹ (AUTHOR); Pond, G.² (AUTHOR); Nassar, A.³ (AUTHOR)

Subjects: *IMMUNE checkpoint inhibitors; *TUMORS

• Source: Annals of Oncology. 2022 Supplement 7, Vol. 33, pS591-S592. 2p.

Record details

Human rabies control in Lebanon: a call for action.

• Authors : Kassir, M. F.; El Zarif, T.; Kassir, G.

• Source: Epidemiology & Infection; Jan2019, Vol. 147, pN.PAG-N.PAG, 8p

Record details

A LONGITUDINAL STUDY OF IMPULSE OSCILLOMETRY AND RESPIRATORY MECHANICS IN PREGNANCY: IMPLICATIONS FOR RESPIRATORY DISORDERS.

• Authors : BOURJEILY, G.; SANAPO, L.; GUILLEN, M.

Subjects: RESPIRATORY mechanics; LONGITUDINAL method; PREGNANCY

• Source: CHEST; 2022 Supplement, Vol. 161 Issue 6, pA500-A500, 1p

Record details

1206O Clinical subtyping of cancer from blood based on comprehensive epigenomic profiling.

• Authors : Baca, S.¹ (AUTHOR); Seo, J-H.¹ (AUTHOR); Berchuck, J.E.¹ (AUTHOR)

• Source: Annals of Oncology. 2023 Supplement 2, Vol. 34, pS711-S711. 1p.

Record details

COVID-19 vaccination and breakthrough infections in patients with cancer.

• Authors : Schmidt, A.L.¹ (AUTHOR); Labaki, C.¹ (AUTHOR); Hsu, C.-Y.^1,2 (AUTHOR)

Subjects: *BREAKTHROUGH infections; *COVID-19 vaccines; *CANCER patients

• Source: Annals of Oncology. Mar2022, Vol. 33 Issue 3, p340-346. 7p.

Record details

Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes.

• Authors : Saliby RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Center of Molecular and Cellular Oncology (CMCO), Yale University, New Haven, CT, USA.

• Source: Cancer cell [Cancer Cell] 2024 Apr 04. Date of Electronic Publication: 2024 Apr 04.Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Clinical outcomes and safety of immune checkpoint inhibitors in patients with solid tumors and paraneoplastic syndromes.

• Authors : Nassar AH; Yale University, New Haven, Connecticut, USA .; El Zarif T

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/drug therapy ; Paraneoplastic Syndromes*/Paraneoplastic Syndromes*/Paraneoplastic Syndromes*/drug therapy

• Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Mar 05; Vol. 12 (3). Date of Electronic Publication: 2024 Mar 05.Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Author Correction: Liquid biopsy epigenomic profiling for cancer subtyping.

• Authors : Baca SC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.

• Source: Nature medicine [Nat Med] 2024 Mar; Vol. 30 (3), pp. 907.Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN:

Record details

The impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort study.

• Authors : Castellano CA; Sun T ...

• Source: Cancer [Cancer] 2024 Feb 20. Date of Electronic Publication: 2024 Feb 20.Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142

Record details

Comparison of outcomes for Hispanic and non-Hispanic patients with advanced renal cell carcinoma in the International Metastatic Renal Cell Carcinoma Database.

• Authors : Guram K; University of California, San Diego Health, La Jolla, California, USA.; Huang J

• Source: Cancer [Cancer] 2024 Jan 31. Date of Electronic Publication: 2024 Jan 31.Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142

Record details